Related Experiment Video
Updated: Aug 11, 2026

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
Published on: May 10, 2019
Drugs and double binds: racial identification and pharmacogenomics in a system of binary race logic
1Department of Communication Studies, Vanderbilt University, Nashville, TN 37235-1505, USA. lynchjoa@uga.edu
Abstract:
People respond to drugs in different ways depending on their genotype. Some geneticists and medical researchers have suggested using race as a substitute for genotype in prescribing medication. Overall, individuals resist the prescription of medication based on race, but some minority individuals, although indicating resistance and suspicion, ultimately choose race-based medication. This can be explained by the operation of Burkean identification in a system of binary race logic. Although individuals resist race-based medication and recognize race is not a legitimate genetic category, their identification with a racial-ethnic group places them in a double bind between choosing race-based medication or denying their racial identification.
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Drug Metabolism: Overview
Stereotypes, Prejudice, and Discrimination
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Drug toxicity: Idiosyncratic Reactions
Pharmacogenomics: Identification of New Drug Targets